2025 · 3rd Quarter (July 1 - Sep 30)
Filed by ACADIA PHARMACEUTICALS.
Open official filingSource-reported fields
Expense method: A
Literal source text
Implementation of the Inflation Reduction Act of 2022, Orphan Cures Act (HR 946, S 1862), Give Kids A Chance (HR 1262, S 932), Cameron's Law (HR 1414), Accelerating Kids Access to Care Act (HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930).
Literal federal measure citations: HR 946, S 1862, HR 1262, S 932, HR 1414, HR 1509, S 752, HR 3731, S 1930
Implementation of the Inflation Reduction Act of 2022, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Orphan Cures Act (HR 946, S 1862), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Accelerating Kids Access to Care Act (HR 1509, S 752).
Literal federal measure citations: HR 946, S 1862, HR 1492, S 832, HR 1, HR 1509, S 752
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
